|
2.0556%
| NASDAQ | US68621F1021 | ORGO-US | Organogenesis Holdings, Inc. Class A |
1
|
|
1.8772%
| NASDAQ | US92346J1088 | VCEL-US | Vericel Corporation |
2
|
|
1.7339%
| NASDAQ | US88025U1097 | TXG-US | 10x Genomics Inc Class A |
3
|
|
1.7087%
| NASDAQ | US82489T1043 | SWAV-US | Shockwave Medical, Inc. |
4
|
|
1.6797%
| NASDAQ | US8523123052 | STAA-US | STAAR Surgical Company |
5
|
|
1.6654%
| NASDAQ | US91307C1027 | UTHR-US | United Therapeutics Corporation |
6
|
|
1.6472%
| NASDAQ | US56400P7069 | MNKD-US | MannKind Corporation |
7
|
|
1.6252%
| NYSE AMERICAN | US45685K1025 | INFU-US | InfuSystem Holdings, Inc. |
8
|
|
1.5846%
| NASDAQ | US2321091082 | CUTR-US | Cutera, Inc. |
9
|
|
1.5710%
| NASDAQ | US0234361089 | AMED-US | Amedisys, Inc. |
10
|
|
1.5500%
| NASDAQ | US40131M1099 | GH-US | Guardant Health, Inc. |
11
|
|
1.5426%
| NASDAQ | US09073M1045 | TECH-US | Bio-Techne Corporation |
12
|
|
1.5415%
| NYSE | US9418481035 | WAT-US | Waters Corporation |
13
|
|
1.5366%
| NASDAQ | US1167941087 | BRKR-US | Bruker Corporation |
14
|
|
1.5340%
| NASDAQ | US74340E1038 | PGNY-US | Progyny, Inc. |
15
|
|
1.5317%
| NASDAQ | US45780L1044 | INGN-US | Inogen, Inc. |
16
|
|
1.5197%
| NASDAQ | US8257041090 | SIBN-US | SI-BONE, Inc. |
17
|
|
1.5157%
| NASDAQ | US47973J1025 | JYNT-US | Joint Corp |
18
|
|
1.5151%
| NYSE | US5926881054 | MTD-US | Mettler-Toledo International Inc. |
19
|
|
1.5122%
| NASDAQ | US03475V1017 | ANGO-US | AngioDynamics, Inc. |
20
|
|
1.5063%
| NYSE | US00846U1016 | A-US | Agilent Technologies, Inc. |
21
|
|
1.4950%
| NASDAQ | US0162551016 | ALGN-US | Align Technology, Inc. |
22
|
|
1.4933%
| NASDAQ | US05368M1062 | CDMO-US | Avid Bioservices, Inc. |
23
|
|
1.4859%
| NASDAQ | US87357P1003 | TCMD-US | Tactile Systems Technology, Inc. |
24
|
|
1.4715%
| NASDAQ | US92337F1075 | VCYT-US | Veracyte Inc |
25
|
|
1.4664%
| NYSE | US29415F1049 | NVST-US | Envista Holdings Corp. |
26
|
|
1.4660%
| NASDAQ | US60783X1046 | MODV-US | Providence Service Corporation |
27
|
|
1.4517%
| NASDAQ | US02081G2012 | ATEC-US | Alphatec Holdings, Inc. |
28
|
|
1.4494%
| NASDAQ | US68213N1090 | OMCL-US | Omnicell, Inc. |
29
|
|
1.4427%
| NASDAQ | US5255582018 | LMAT-US | LeMaitre Vascular, Inc. |
30
|
|
1.4239%
| NASDAQ | US78667J1088 | SAGE-US | SAGE Therapeutics, Inc. |
31
|
|
1.4223%
| NASDAQ | US67020Y1001 | NUAN-US | Nuance Communications, Inc. |
32
|
|
1.4200%
| NASDAQ | US14167L1035 | CDNA-US | CareDx, Inc. |
33
|
|
1.4130%
| NASDAQ | US68401U2042 | OPRX-US | OptimizeRx Corporation |
34
|
|
1.4010%
| NASDAQ | US1567821046 | CERN-US | Cerner Corporation |
35
|
|
1.3986%
| NASDAQ | US60770K1079 | MRNA-US | Moderna, Inc. |
36
|
|
1.3970%
| NASDAQ | US4579852082 | IART-US | Integra LifeSciences Holdings Corporation |
37
|
|
1.3926%
| NASDAQ | US42805E3062 | HSKA-US | Heska Corporation |
38
|
|
1.3898%
| NASDAQ | US40637H1095 | HALO-US | Halozyme Therapeutics, Inc. |
39
|
|
1.3849%
| NASDAQ | US0043971052 | ARAY-US | Accuray Incorporated |
40
|
|
1.3833%
| NYSE | US4781601046 | JNJ-US | Johnson & Johnson |
41
|
|
1.3812%
| NASDAQ | US04963C2098 | ATRC-US | AtriCure, Inc. |
42
|
|
1.3792%
| NASDAQ | US6390501038 | NTUS-US | Natus Medical Incorporated |
43
|
|
1.3684%
| NYSE | US0028241000 | ABT-US | Abbott Laboratories |
44
|
|
1.3643%
| NYSE | US2166484020 | COO-US | Cooper Companies, Inc. |
45
|
|
1.3638%
| NASDAQ | US44934S2068 | ICAD-US | iCAD, Inc. |
46
|
|
1.3591%
| NASDAQ | US45168D1046 | IDXX-US | IDEXX Laboratories, Inc. |
47
|
|
1.3495%
| NASDAQ | US6323071042 | NTRA-US | Natera, Inc. |
48
|
|
1.3369%
| NASDAQ | US14843C1053 | CSTL-US | Castle Biosciences, Inc. |
49
|
|
1.3315%
| NYSE | US4577301090 | INSP-US | Inspire Medical Systems, Inc. |
50
|
|
1.3260%
| NASDAQ | US0366421065 | ATRS-US | Antares Pharma, Inc. |
51
|
|
1.3217%
| NASDAQ | US05463X1063 | AXGN-US | AxoGen, Inc. |
52
|
|
1.3209%
| NASDAQ | IE00B4Q5ZN47 | JAZZ-US | Jazz Pharmaceuticals Plc |
53
|
|
1.3204%
| NASDAQ | US7493971052 | RCM-US | R1 RCM Inc |
54
|
|
1.3112%
| NASDAQ | US3596641098 | FLGT-US | Fulgent Genetics, Inc. |
55
|
|
1.3098%
| NYSE | US90328M1071 | USNA-US | USANA Health Sciences, Inc. |
56
|
|
1.3037%
| NYSE | US3773221029 | GKOS-US | Glaukos Corp |
57
|
|
1.3017%
| NASDAQ | JE00BYSS4X48 | NVCR-US | Novocure Ltd. |
58
|
|
1.3006%
| NASDAQ | US62855J1043 | MYGN-US | Myriad Genetics, Inc. |
59
|
|
1.2853%
| NYSE | US4050241003 | HAE-US | Haemonetics Corporation |
60
|
|
1.2767%
| NASDAQ | US89422G1076 | TVTX-US | Travere Therapeutics, Inc. |
61
|
|
1.2473%
| NASDAQ | US68752M1080 | OFIX-US | Orthofix Medical, Inc. |
62
|
|
1.2357%
| NASDAQ | US7504692077 | RDUS-US | Radius Health, Inc. |
63
|
|
1.2200%
| NASDAQ | US9216591084 | VNDA-US | Vanda Pharmaceuticals Inc. |
64
|
|
1.2186%
| NYSE | US71944F1066 | PHR-US | Phreesia, Inc. |
65
|
|
1.2080%
| NYSE | US5324571083 | LLY-US | Eli Lilly and Company |
66
|
|
1.2056%
| NYSE | US92857F1075 | VCRA-US | Vocera Communications, Inc. |
67
|
|
1.1908%
| NASDAQ | US1416191062 | CSII-US | Cardiovascular Systems, Inc. |
68
|
|
1.1454%
| NASDAQ | US90400D1081 | RARE-US | Ultragenyx Pharmaceutical, Inc. |
69
|
|
1.1149%
| NASDAQ | US92536C1036 | VERU-US | Veru Inc |
70
|
